Rising Prevalence Of Neurodegenerative Disorders Driving Growth In The Market Due To Aging Population And Longer Life Expectancy Is Supporting Development Across The Dementia Treatment Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

By 2030, How Much Growth In Market Size Is Expected For The Dementia Treatment Market?

The dementia treatment market has experienced robust growth in recent years. Its valuation is set to climb from $19.95 billion in 2025 to $21.81 billion in 2026, advancing at a compound annual growth rate (CAGR) of 9.3%. The market’s historical growth is largely due to an aging global population, the increasing prevalence of Alzheimer’s disease, enhanced diagnosis rates, the continued use of cholinesterase inhibitors, and the expansion of geriatric healthcare services.

The dementia treatment market is anticipated to experience substantial expansion in the coming years. Its value is projected to reach $31.13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.3%. This projected increase can be ascribed to advancements in precision medicine, an escalating need for therapies that modify the disease’s progression, greater financial input into neurodegenerative research, the proliferation of homecare treatment options, and enhanced capabilities for early diagnosis. Key developments expected during this period involve a greater uptake of combined drug treatments, an intensified focus on interventions for dementia in its initial stages, a surge in the application of symptom management therapies, the broadening of non-pharmacological care strategies, and a stronger emphasis on individualized treatment regimens.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24200&type=smp

Which Significant Factors Are Encouraging Growth In The Dementia Treatment Market?

The increasing occurrence of neurodegenerative conditions is expected to fuel the expansion of the dementia treatment market over the next few years. These disorders are characterized by the progressive deterioration and loss of neurons, resulting in worsening difficulties with movement, thought processes, or both. The increase in neurodegenerative disorders is primarily fueled by the demographic shift towards an older population; extended lifespans elevate the likelihood of developing age-associated conditions like Alzheimer’s and Parkinson’s disease, with age being the foremost determinant. A deeper comprehension of neurodegenerative disorders improves dementia treatment by facilitating more accurate diagnoses and specialized therapies, since identifying the exact underlying ailment permits a tailored and more successful strategy for symptom management. For example, in April 2024, a report from the Alzheimer’s Association, a US-based non-profit health organization, indicated that around 6.9 million Americans aged 65 and older suffered from Alzheimer’s dementia, with this number anticipated to double to 13.8 million by 2060. Consequently, the rising occurrence of neurodegenerative disorders is set to propel the expansion of the dementia treatment market.

What Are The Core Segment Classifications In The Dementia Treatment Market?

The dementia treatment market covered in this report is segmented –

1) By Treatment Type: Antipsychotics, Cholinesterase Inhibitors, Memantine

2) By Indication: Alzheimer’s Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia, Parkinson Disease Dementia, Other Indications

3) By Route of Administration: Oral, Transdermal Patch, Injectable

4) By Stage of Dementia: Mild Dementia, Moderate Dementia, Severe Dementia

5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Antipsychotics: Atypical Antipsychotics, Typical Antipsychotics

2) By Cholinesterase Inhibitors: Donepezil, Rivastigmine, Galantamine

3) By Memantine: Memantine Monotherapy, Memantine Combination Therapy

Which Trends Are Influencing The Expansion Of The Dementia Treatment Market?

Major companies operating in the dementia treatment market are concentrating on developing technologically advanced solutions, such as virtual reality (VR) training programs, designed to simulate complex and diverse scenarios. These VR training programs are immersive, computer-generated simulations that enable individuals to practice and develop skills within a controlled, interactive, and realistic virtual environment. For instance, in September 2024, Otsuka Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company, collaborated with Jolly Good Inc., a Japan-based medical technology company, to launch FACEDUO, a virtual reality training program for dementia care. This interactive VR tool, guided by medical experts, assists caregivers, including family members, in understanding the emotions and behaviors of people with dementia. Simulating real-life scenarios allows caregivers to respond more effectively to the unique needs of dementia patients. The program aims to enhance caregiving skills and empathy for more effective support.

Who Are The Key Market Participants In The Dementia Treatment Market?

Major companies operating in the dementia treatment market are Biogen Inc., Eisai Co. Ltd., Eli Lilly and Company, Roche Holding AG, AbbVie Inc., Sanofi S.A., Amgen Inc., Merz Pharmaceuticals GmbH, Acadia Pharmaceuticals Inc., Intra-Cellular Therapies Inc., Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S, Pfizer Inc., Novartis AG, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Cerevance Inc., AviadoBio Ltd., Cassava Sciences Inc., Anavex Life Sciences Corp.

Access The Complete Dementia Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/dementia-treatment-global-market-report

Which Area Represents The Largest Portion Of The Dementia Treatment Market?

North America was the largest region in the dementia treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dementia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Dementia Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24200&type=smp

Browse Through More Reports Similar to the Global Dementia Treatment Market 2026, By The Business Research Company

Lewy Body Dementia Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-treatment-global-market-report

Alzheimers Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report

Alzheimers Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795